Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Apr 15, 2026; 18(4): 116420
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.116420
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.116420
Table 1 Comparison of handgrip strength and serum albumin levels between two patient groups, mean ± SD
| Indicator | Time point | Intervention group (n = 40) | Control group (n = 40) | F value (group/time/interaction) | P value |
| HGS (kg) | T0 | 28.62 ± 4.28 | 29.09 ± 5.02 | ||
| T1 | 16.38 ± 3.19 | 14.22 ± 3.41 | 44.87/156.30/9.21 | 0.00 | |
| T2 | 25.40 ± 3.96 | 20.37 ± 4.15 | |||
| T3 | 27.19 ± 3.72 | 21.80 ± 4.32 | |||
| Albumin (g/L) | T0 | 41.22 ± 2.81 | 40.91 ± 3.02 | ||
| T1 | 36.56 ± 2.46 | 32.19 ± 3.20 | 160.90/69.10/10.23 | 0.00 | |
| T2 | 39.87 ± 2.69 | 34.71 ± 2.98 | |||
| T3 | 40.59 ± 2.34 | 35.29 ± 2.76 |
Table 2 Comparison of interleukin-6 and phase angle levels between two patient groups, mean ± SD
| Indicator | Time point | Intervention group (n = 40) | Control group (n = 40) | F value (group/time/interaction) | P value |
| IL-6 (pg/mL) | T0 | 5.22 ± 1.10 | 5.40 ± 1.32 | ||
| T1 | 28.42 ± 6.21 | 45.73 ± 9.84 | |||
| T2 | 8.17 ± 1.93 | 14.32 ± 3.25 | 210.60/827.50/51.12 | 0.00 | |
| T3 | 6.32 ± 1.43 | 11.88 ± 2.70 | |||
| Phase angle (°) | T0 | 6.11 ± 0.52 | 6.03 ± 0.65 | ||
| T1 | 5.33 ± 0.62 | 4.55 ± 0.73 | 126.40/43.93/13.29 | 0.00 | |
| T2 | 5.82 ± 0.66 | 4.62 ± 0.77 | |||
| T3 | 6.02 ± 0.55 | 4.82 ± 0.65 |
Table 3 Comparison of timed up and go walking time and compound muscle action potential amplitude/area ratio levels between two patient groups, mean ± SD
| Indicator | Time point | Intervention group (n = 40) | Control group (n = 40) | t-value (group/time/interaction) | P value |
| TUG (seconds) | T2 | 11.29 ± 2.18 | 15.85 ± 3.20 | 7.45 | 0.00 |
| T3 | 9.80 ± 1.73 | 14.20 ± 2.01 | 10.49 | 0.00 | |
| CMAP A/A ratio | T2 | 0.82 ± 0.07 | 0.65 ± 0.09 | 9.43 | 0.00 |
| T3 | 0.85 ± 0.06 | 0.68 ± 0.08 | 10.75 | 0.00 |
Table 4 Comparison of clinical outcome indicators, n (%)
| Indicator | Intervention group (n = 40) | Control group (n = 40) | t/χ2 | P value |
| Time to recovery of somatic function (days), mean ± SD | 18.31 ± 4.24 | 25.76 ± 6.85 | 5.85 | 0.00 |
| Falls in the past 30 days | 1 (2.50) | 8 (20.00) | 0.03 | |
| Non-planned readmissions within 90 days | 2 (5.00) | 10 (25.00) | 0.03 |
Table 5 Multivariate linear regression analysis of the impact of multimodal rehabilitation nursing intervention and biological indicators on time to functional recovery (n = 80)
| Variable | Regression coefficient (β) | SE | 95% confidence interval | t-value | P value |
| Intervention group (intervention = 1) | -6.82 | 0.82 | -8.45 to -5.19 | -8.32 | 0.00 |
| Age (per 1-year increase) | 0.21 | 0.13 | -0.05 to 0.47 | 1.62 | 0.11 |
| Open surgery (yes = 1) | 1.84 | 0.97 | -0.10 to 3.78 | 1.90 | 0.06 |
| Gastric cancer | 0.63 | 1.12 | -1.60 to 2.86 | 0.56 | 0.58 |
| T1 IL-6 (per 1 pg/mL increase) | 0.78 | 0.31 | 0.16 to 1.40 | 2.52 | 0.01 |
| T2 HGS (per 1 kg increase) | -1.23 | 0.28 | -1.79 to -0.67 | -4.39 | 0.00 |
| T2 TUG (per 1 second increase) | 2.15 | 0.42 | 1.31 to 2.99 | 5.12 | 0.00 |
| T2 CMAP A/A ratio (per 0.1 increase) | -3.04 | 0.58 | -4.20 to -1.88 | -5.24 | 0.00 |
- Citation: Chen J, Zhang AQ. Impact of multimodal rehabilitation on physical function in post-intensive care syndrome patients after gastrointestinal tumor surgery. World J Gastrointest Oncol 2026; 18(4): 116420
- URL: https://www.wjgnet.com/1948-5204/full/v18/i4/116420.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i4.116420
